Form4insider filings, from the source

SEC Form 3 · accession 0001209191-16-088115

Insight Molecular Diagnostics Inc. · IMDX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Dec 30, 2015
Accepted (ET)
Jan 4, 2016 · 9:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001642380

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, no par valueholding———43,799D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Option to Purchase Common StockF1$1.34holding————Dec 28, 2020Common Stock250,000—D
Option to Purchase Common StockF2$2.20holding————Jan 8, 2025Common Stock125,000—D
Option to Purchase Common StockF3$1.50holding————Mar 31, 2018Common Stock200,000—I
Option to Purchase Common StockF4$2.20holding————Jan 8, 2025Common Stock100,000—I

Explanation of responses